Alterity Therapeutics (ATHE) Enterprise Value (2017 - 2018)
Alterity Therapeutics (ATHE) has 2 years of Enterprise Value data on record, last reported at -$11.5 million in Q2 2018.
- For Q2 2018, Enterprise Value rose 29.84% year-over-year to -$11.5 million; the TTM value through Jun 2018 reached -$11.5 million, up 29.84%, while the annual FY2018 figure was -$11.5 million, 30.11% up from the prior year.
- Enterprise Value reached -$11.5 million in Q2 2018 per ATHE's latest filing, up from -$16.4 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$11.5 million in Q2 2018 and bottomed at -$16.4 million in Q2 2017.